Zorina S. Galis, Ph.D. is the Chief of Vascular Biology and Hypertension at the National Heart, Lung, and Blood Institute (NHLBI) /National Institutes of Health (NIH), overseeing a large and diverse extramural portfolio of basic, translational, and clinical research. Zorina also participates in organizing scientific conferences and servers as a reviewer for professional journals, foreign government and non-government biomedical agencies. Previously Zorina rose through the academic ranks at Harvard Medical School, and then to a tenured position in Emory School of Medicine and Georgia Institute of Technology. Subsequently, Zorina simultaneously held the positions of Chief Scientific Officer, Cardiovascular R&D at Eli Lilly and Co. and Professor of Vascular Surgery, at Indiana University. Zorina is recognized for her significant scientific contributions to the area of vascular remodeling, in relation to acute clinical syndromes, hypertension, and bioengineered grafts. She has excelled in establishing, training, and leading successful interdisciplinary teams of scientists, engineers, cardiology and surgical fellows, drug developers, and of research administrators. Zorina was trained in physics, biophysics, cell biology, pathology, and vascular medicine at the University of Bucharest, Romania, the McGill University School of Medicine, Montreal, Canada, and the Harvard School of Medicine, Boston, USA.